Greenphire Expands Global Travel Solution, ConneX
Greenphire has announced the expansion and growth of ConneX, a clinical trial travel solution designed to help meet the retention goals of global studies.
ConneX has expanded upon its in-market resources in key regions, including Japan, Central and Southern Europe, Scandinavia, and Southeast Asia.
In support of global trial retention, ConneX offers a host of personalized concierge services, including air, train, hotel, car services and rideshare, ambulatory care, and specialty services. This includes travel visa support, with successful applications recently processed for patients traveling from Jordan to Germany and Iraq to the USA.
Reference
Greenphire's ConneX Global Travel Solution Expands In-Country Support, Resulting in Significant Growth as Clinical Trial Travel Returns Post-Pandemic. (2023, February 28). Cision PR Newswire.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
